Chiral recognition of metalaxyl enantiomers by human serum albumin: Evidence from molecular modeling and photophysical approach

Chirality

Volumn 24, Issue 6, 2012, Pages 471-480

  Ding, Fei ^a   Li, Xiu Nan ^b   Diao, Jian Xiong ^a   Sun, Ye ^a   Zhang, Li ^a   Sun, Ying ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF PROCESS ENGINEERING   (China)

Author keywords

circular dichroism; fluorescence; human serum albumin; metalaxyl enantiomers; molecular modeling; stereoselectivity

Indexed keywords

8 ANILINO 1 NAPHTHALENESULFONIC ACID; CHLORIDE; GUANIDINE; HUMAN SERUM ALBUMIN; METALAXYL; POLYPEPTIDE;

ARTICLE; BINDING AFFINITY; CHIRALITY; CIRCULAR DICHROISM; ENANTIOMER; FLUORESCENCE ANALYSIS; HUMAN; HYDROGEN BOND; HYDROPHOBIC INTERACTION CHROMATOGRAPHY; LIGAND BINDING; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN UNFOLDING;

ALANINE; ALKALOIDS; CHEMISTRY TECHNIQUES, ANALYTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MODELS, MOLECULAR; SERUM ALBUMIN; STEREOISOMERISM;

EID: 84861576539     PISSN: 08990042     EISSN: 1520636X     Source Type: Journal    
DOI: 10.1002/chir.22024     Document Type: Article

References (61)

1. He XM, Carter DC,. Atomic structure and chemistry of human serum albumin. Nature 1992; 358: 209-215.
2. Carter DC,. Crystallographic survey of albumin drug interaction and preliminary applications in cancer chemotherapy. In:, Abraham DJ, Rotella DP, editors. Burger's medicinal chemistry, drug discovery and development. Hoboken: John Wiley & Sons, Inc.; 2010. p 437-467.
3. Curry S,. Lessons from the crystallographic analysis of small molecule binding to human serum albumin. Drug Metab Pharmacokinet 2009; 24: 342-357.
4. Varshney A, Sen P, Ahmad E, Rehan M, Subbarao N, Khan RH,. Ligand binding strategies of human serum albumin: how can the cargo be utilized? Chirality 2010; 22: 77-87.
5. Chuang VTG, Otagiri M,. Stereoselective binding of human serum albumin. Chirality 2006; 18: 159-166.
6. Müller WE, Wollert U,. High stereospecificity of the benzodiazepine binding site on human serum albumin. Studies with d- and l-oxazepam hemisuccinate. Mol Pharmacol 1975; 11: 52-60.
7. Manzini G, Ciana A, Crescenzi V,. The interaction of serum albumins with various drugs in aqueous solution. Gel permeation, calorimetric, and fluorescence data. Biophys Chem 1979; 10: 389-396.
8. Domenici E, Bertucci C, Salvadori P, Motellier S, Wainer IW,. Immobilized serum albumin: rapid HPLC probe of stereoselective protein-binding interactions. Chirality 1990; 2: 263-268.
9. Domenici E, Bertucci C, Salvadori P, Wainer IW,. Use of a human serum albumin-based high-performance liquid chromatography chiral stationary phase for the investigation of protein binding: detection of the allosteric interaction between warfarin and benzodiazepine binding sites. J Pharm Sci 1991; 80: 164-166.
10. Chen JZ, Hage DS,. Quantitative analysis of allosteric drug-protein binding by biointeraction chromatography. Nat Biotechnol 2004; 22: 1445-1448.
11. Monti S, Manoli F, Sortino S, Morrone R, Nicolosi G,. Binding of a chiral drug to a protein: an investigation of the 2-(3-benzoylphenyl)propionic acid/bovine serum albumin system by circular dichroism and fluorescence. Phys Chem Chem Phys 2005; 7: 4002-4008.
12. Monti S, Manet I, Manoli F, Morrone R, Nicolosi G, Sortino S,. Diastereoselectivity and site dependency in the photochemistry of ketoprofen in the bovine serum albumin matrix. Photochem Photobiol 2006; 82: 13-19.
13. Monti S, Manet I, Manoli F, Sortino S,. Binding and photochemistry of enantiomeric 2-(3-benzoylphenyl)propionic acid (ketoprofen) in the human serum albumin environment. Photochem Photobiol Sci 2007; 6: 462-470.
14. Monti S, Ottani S, Manoli F, Manet I, Scagnolari F, Zambelli B, Marconi G,. Chiral recognition of 2-(3-benzoylphenyl)propionic acid (ketoprofen) by serum albumin: an investigation with microcalorimetry, circular dichroism and molecular modelling. Phys Chem Chem Phys 2009; 11: 9104-9113.
15. Monti S, Manet I, Marconi G,. Combination of spectroscopic and computational methods to get an understanding of supramolecular chemistry of drugs: from simple host systems to biomolecules. Phys Chem Chem Phys 2011; 13: 20893-20905.
16. Bertucci C, Simone AD, Pistolozzi M, Rosini M,. Reversible human serum albumin binding of lipocrine: a circular dichroism study. Chirality 2011; 23: 827-832.
17. Taylor SH,. The efficacy of amlodipine in myocardial ischemia. Am Heart J 1989; 118: 1123-1126.
18. Lukša J, Josič D, Kremser M, Kopitar Z, Milutinovič S,. Pharmacokinetic behaviour of R-(+)- and S-(-)-amlodipine after single enantiomer administration. J Chromatogr B 1997; 703: 185-193.
19. Ohmori M, Arakawa M, Harada K, Takasaki H, Hifumi S, Miyamori I, Fujimura A,. Stereoselective pharmacokinetics of amlodipine in elderly hypertensive patients. Am J Ther 2003; 10: 29-31.
20. Ascoli GA, Domenici E, Bertucci C,. Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism. Chirality 2006; 18: 667-679.
21. Pérez-Fernández V, García MÁ, Marina ML,. Chiral separation of metalaxyl and benalaxyl fungicides by electrokinetic chromatography and determination of enantiomeric impurities. J Chromatogr A 2011; 1218: 4877-4885.
22. Zhang XX, Xia TT, Chen JW, Huang LP, Cai XY,. Direct chiral resolution of metalaxyl and metabolite metalaxyl acid in aged mobile phases: the role of trace water. J Agric Food Chem 2010; 58: 5004-5010.
23. Abass K, Reponen P, Jalonen J, Pelkonen O,. In vitro metabolism and interactions of the fungicide metalaxyl in human liver preparations. Environ Toxicol Pharmacol 2007; 23: 39-47.
24. Monkiedje A, Ilori MO, Spiteller M,. Soil quality changes resulting from the application of the fungicides mefenoxam and metalaxyl to a sandy loam soil. Soil Biol Biochem 2002; 34: 1939-1948.
25. Saab J, Bassil G, Naccoul RA, Stephan J, Mokbel I, Jose J,. Salting-out phenomenon and 1-octanol/water partition coefficient of metalaxyl pesticide. Chemosphere 2011; 82: 929-934.
26. Paolini M, Mesirca R, Pozzetti L, Sapone A, Cantelli-Forti G,. Biomarkers of effect in evaluating metalaxyl cocarcinogenesis selective induction of murine CYP 3A isoform. Mutat Res Environ Mutagen Relat Subj 1996; 361: 157-164.
27. Qiu J, Wang QX, Wang P, Jia GF, Li JL, Zhou ZQ,. Enantioselective degradation kinetics of metalaxyl in rabbits. Pestic Biochem Physiol 2005; 83: 1-8.
28. Chignell CF, Starkweather DK,. Optical studies of drug-protein complexes: V. The interaction of phenylbutazone, flufenamic acid, and dicoumarol with acetylsalicylic acid-treated human serum albumin. Mol Pharmacol 1971; 7: 229-237.
29. Yera ER, Cleves AE, Jain AN,. Chemical structural novelty: on-targets and off-targets. J Med Chem 2011; 54: 6771-6785.
30. Lakowicz JR,. Principles of fluorescence spectroscopy. New York: Springer Science + Business Media; 2006. p 27-61, 277-330, 577-606.
31. Sreerama N, Woody RW,. Computation and analysis of protein circular dichroism spectra. Methods Enzymol 2004; 383: 318-351.
32. Stern O, Volmer M,. Über die Abklingungszeit der Fluoreszenz. Phys Z 1919; 20: 183-188.
33. Abou-Zied OK, Al-Shihi OIK,. Characterization of subdomain IIA binding site of human serum albumin in its native, unfolded, and refolded states using small molecular probes. J Am Chem Soc 2008; 130: 10793-10801.
34. Abou-Zied OK, Al-Lawatia N,. Exploring the drug-binding site Sudlow I of human serum albumin: the role of water and Trp214 in molecular recognition and ligand binding. Chemphyschem 2011; 12: 270-274.
35. Abou-Zied OK,. Revealing the ionization ability of binding site I in human serum albumin using 2-(2'-hydroxyphenyl)benzoxazole as a pH sensitive probe. Phys Chem Chem Phys 2011; doi: 10.1039/C2CP23337A.
36. Abou-Zied OK,. Investigating 2,2'-bipyridine-3,3'-diol as a microenvironment-sensitive probe: its binding to cyclodextrins and human serum albumin. J Phys Chem B 2007; 111: 9879-9885.
37. Endo S, Goss K-U,. Serum albumin binding of structurally diverse neutral organic compounds: data and models. Chem Res Toxicol 2011; 24: 2293-2301.
38. Lucek RW, Coutinho CB,. The role of substituents in the hydrophobic binding of the 1,4-benzodiazepines by human plasma proteins. Mol Pharmacol 1976; 12: 612-619.
39. Karlsson BCG, Rosengren AM, Andersson PO, Nicholls IA,. The spectrophysics of warfarin: implications for protein binding. J Phys Chem B 2007; 111: 10520-10528.
40. González-Béjar M, Alarcón E, Poblete H, Scaiano JC, Pérez-Prieto J,. Stereoselective interaction of epimeric naproxen-RGD peptides with human serum albumin. Biomacromolecules 2010; 11: 2255-2260.
41. Zsila F, Bikadi Z, Malik D, Hari P, Pechan I, Berces A, Hazai E,. Evaluation of drug-human serum albumin binding interactions with support vector machine aided online automated docking. Bioinformatics 2011; 27: 1806-1813.
42. Sudlow G, Birkett DJ, Wade DN,. The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol 1975; 11: 824-832.
43. Ascenzi P, di Madi A, Sanctis GD, Coletta M, Fasano M,. Ibuprofen modulates allosterically NO dissociation from ferrous nitrosylated human serum heme-albumin by binding to three sites. Biochem Biophys Res Commun 2009; 387: 83-86.
44. Brodersen R, Sjödin T, Sjöholm I,. Independent binding of ligands to human serum albumin. J Biol Chem 1977; 252: 5067-5072.
45. Ahmad B, Ahmed MZ, Haq SK, Khan RH,. Guanidine hydrochloride denaturation of human serum albumin originates by local unfolding of some stable loops in domain III. Biochim Biophys Acta-Proteins Proteomics 2005; 1750: 93-102.
46. Galantini L, Leggio C, Pavel NV,. Human serum albumin unfolding: a small-angle X-ray scattering and light scattering study. J Phys Chem B 2008; 112: 15460-15469.
47. Weber G, Daniel E,. Cooperative effects in binding by bovine serum albumin. II. The binding of 1-anilino-8-naphthalenesulfonate. Polarization of the ligand fluorescence and quenching of the protein fluorescence. Biochemistry 1966; 5: 1900-1907.
48. Stryer L,. The interaction of a naphthalene dye with apomyoglobin and apohemoglobin: a fluorescent probe of non-polar binding sites. J Mol Biol 1965; 13: 482-495.
49. Bagatolli LA, Kivatinitz SC, Aguilar F, Soto MA, Sotomayor P, Fidelio GD,. Two distinguishable fluorescent modes of 1-anilino-8-naphthalenesulfonate bound to human albumin. J Fluoresc 1996; 6: 33-40.
50. Cattoni DI, Kaufman SB, Flecha FLG,. Kinetics and thermodynamics of the interaction of 1-anilino-naphthalene-8-sulfonate with proteins. Biochim Biophys Acta-Proteins Proteomics 2009; 1794: 1700-1708.
51. Ruiz CC, Hierrezuelo JM, Aguiar J, Peula-García JM,. Physicochemical studies on the interaction between N-decanoyl-N-methylglucamide and bovine serum albumin. Biomacromolecules 2007; 8: 2497-2503.
52. Pace TCS, Nishijima M, Wada T, Inoue Y, Bohne C,. Photophysical studies on the supramolecular photochirogenesis for the photocyclodimerization of 2-anthracenecarboxylate within human serum albumin. J Phys Chem B 2009; 113: 10445-10453.
53. Flora K, Brennan JD, Baker GA, Doody MA, Bright FV,. Unfolding of acrylodan-labeled human serum albumin probed by steady-state and time-resolved fluorescence methods. Biophys J 1998; 75: 1084-1096.
54. Amiri M, Jankeje K, Albani JR,. Origin of fluorescence lifetimes in human serum albumin. Studies on native and denatured protein. J Fluoresc 2010; 20: 651-656.
55. Pistolozzi M, Bertucci C,. Species-dependent stereoselective drug binding to albumin: a circular dichroism study. Chirality 2008; 20: 552-558.
56. Rodger A, Marrington R, Roper D, Windsor S,. Circular dichroism spectroscopy for the study of protein-ligand interactions. In:, Nienhaus GU, editor. Protein-ligand interactions: methods and applications. Totowa: Humana Press, Inc.; 2005. p 343-363.
57. Kelly SM, Jess TJ, Price NC,. How to study proteins by circular dichroism. Biochim Biophys Acta-Proteins Proteomics 2005; 1751: 119-139.
58. Sevilla P, Rivas JM, García-Blanco F, García-Ramos J, Sánchez-Cortés S,. Identification of the antitumoral drug emodin binding sites in bovine serum albumin by spectroscopic methods. Biochim Biophys Acta-Proteins Proteomics 2007; 1774: 1359-1369.
59. De-Llanos R, Sánchez-Cortes S, Domingo C, García-Ramos JV, Sevilla P,. Surface plasmon effects on the binding of antitumoral drug emodin to bovine serum albumin. J Phys Chem C 2011; 115: 12419-12429.
60. Garrison W,. On the issue of enantioselectivity of chiral pesticides: a green chemistry opportunity. Green Chem 2004; 6: G77-G78.
61. Kasprzyk-Hordern B,. Pharmacologically active compounds in the environment and their chirality. Chem Soc Rev 2010; 39: 4466-4503.